Since the Tau pathology correlates to the cognitive deficits observed in AD patients [83, 84], our observation of decreased Tau and Tau-induced cognitive deficits suggests a strong translational potential of inhibiting TSPO. Here, MAPT is linked to Alzheimer disease.